Login / Signup

Author's Reply to Kuss and Rathmann's Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".

John-Michael GambleWajd Alkabbani
Published in: Drug safety (2023)
Keyphrases
  • adverse drug
  • cardiovascular disease
  • electronic health record
  • late onset
  • big data
  • drug induced
  • type diabetes
  • emergency department
  • muscular dystrophy